Subscribe to our Newsletters !!
Fermentation is a natural method which is applied
Precision and careful planning goes into the forma
The human metapneumovirus, more simply referred to
Indegene, a digital-first life sciences commercial
Alembic Pharmaceuticals Limited (Alembic) announce
'Simplicity' seems to be the perfect word to descr
Dear Readers, Welcome to the latest issue of The Magazine
HiGenoMB® Molecular Biology Division of HiMedia Laboratories Pvt. Ltd. the pioneers in Indian BioSciences manufacturing segment adds another feather in the cap with their newly CE/IVD approved Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262).
Molecular Diagnostics based on real-time PCR is increasingly becoming the gold standard post COVID-19. Hi-PCR® COVID-FLU Multiplex Probe PCR Kit, is a multiplex PCR kit that can differentiate between COVID-19 and Flu using a single tube reaction. It is recommended for sensitive and specific detection of SARS-CoV-2 and Influenza virus in clinical samples. Targets include RdRp gene of SARS-CoV-2 virus, Influenza A virus (Swine flu 2009 H1N1 virus, seasonal H3N2 & seasonal H1N1), Influenza B virus and Internal control (IC)
Also read:HiGenoMB-HiMedia announces CDSCO approval for COVID-19 Detection Kit-Dry Swab and Triplex Probe PCR Kit
Covid-19 pandemic has impacted millions of lives globally. The symptoms are similar to those of influenza, both being contagious respiratory illness. As the public’s concern of contracting Covid-19 continued to rise, flu symptoms were frequently mistaken for those of Covid-19. Performing separate tests for detection of Covid-19 and Influenza can be time consuming, costly & a cumbersome affair. HiMedia’s MBPCR262 being a multiplex kit eliminates the need for separate tests thereby significantly reducing the time & resources.
Dr. Kavita Khadke, Director of HiMedia’s Molecular Biology Division (HiGenoMB®) says ‘’An early diagnostic tool that would help to differentiate between Flu and Covid-19 was the need of the hour. Time is of essence; this kit can give results in a short span, enabling rapid and appropriate detection that could help in early diagnosis & treatment.
Please visit our website www.himedialabs.com for more details about HiGenoMB® products related COVID Molecular testing.
HiMedia is one of the largest Indian Biosciences company, providing solutions to over 150 countries worldwide with an all-inclusive product range catering to Microbiology, Molecular Biology, Animal Cell culture, Plant Tissue culture, Bio chemicals, Laboratory Aids, Molecular Diagnostic instruments and more. HiGenoMB® encompasses the Molecular Biology Product Range of HiMedia Laboratories Pvt. Ltd. Comprising of DNA/RNA Extraction kits, PCR reagents, NASBA (Nucleic Acid Sequence Based Amplification tests), Proteomics, Molecular biology grade chemicals and buffers and Instrumentation for Research & Diagnostics. HiGenoMB® has now ventured into service industry with its Hi-Gx360TM services offering a complete portfolio of Sequencing & Bioinformatics solutions in diverse areas. Covering major aspects of the most dynamic branches of the Life Sciences group, HiGenoMB® team strives hard to make molecular work enjoyable with its user friendly product range.
